Treace Medical Concepts Inc (TMCI) — Capital Reinvestment Ratio

Latest as of March 2026: 0.42x

Treace Medical Concepts Inc (TMCI) has a Capital Reinvestment Ratio of 0.42x as of March 2026, meaning it reinvests 0% of its operating cash flow ($7.23 Million) in capital expenditures ($3.06 Million). Check tangible net worth ratio of Treace Medical Concepts Inc to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.42x

Capex / Operating Cash Flow

Operating Cash Flow

$7.23 Million

USD

Capital Expenditures

$3.06 Million

USD

Data as of

Mar 2026

Most recent filing

Annual Capital Reinvestment Ratio for Treace Medical Concepts Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Treace Medical Concepts Inc from None to None. See Treace Medical Concepts Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow